Capture Vascular Ranked as Top 10 Cardiovascular Device Company of 2018

Capture Vascular, Inc. (Capture) has been ranked as a Top 10 Cardiovascular Device Company of 2018 by Medical Tech Outlook Magazine.
 
"We couldn't be more elated to be recognized as one of the Top 10 Cardiovascular Device Companies of 2018," stated Eric Wells, CEO of Capture. "The team has been working hard and 2018 is off to a great start. We continue to generate interest in our commercialized PAD-ATK device. We received the CE Mark in February and continue to receive significant international distribution interest. This has definitely been a very exciting year so far," stated Wells.
 
To add to the momentum, Capture is about to launch its Coronary (CAD) device in September 2018 and anticipates launching its DVT device in Q1 2019.
 
“Dr. Jeffrey Chambers presented Capture's CAD MegaVac Mechanical Thrombectomy System at SCAI 2018 last month in San Diego, CA. Our focus for the balance of 2018 is to get Capture’s devices in the hands of physicians in order to continue to build the data to support the benefits of using the system. We believe that Vascular Surgeons, Interventional Cardiologists, and Interventional Radiologists around the world will find the system effective and easy-to-use in providing proximal occlusion of antegrade blood flow, thereby reducing the potential for an embolic occurrence while performing highly disruptive treatments,” stated Wells.

For the full list of Top Cardiovascular Device Companies as ranked by Medical Tech Outlook Magazine click here.